The phytochemical Honokiol from the Magnolia tree combats neuroinflammation and brain aging

Herbs And Phytochemicals: Researchers from the University of Florence-Italy and Emory School of Medicine-USA have found promising new strategies to combat brain aging and neuroinflammation. Their focus? A natural compound called Honokiol and its synthetic version, Honokiol Hexafluoro. Both have shown potential in reducing neuroinflammation and cellular aging in brain immune cells known as microglia.


The phytochemical Honokiol from the Magnolia tree combats
neuroinflammation and brain aging

What is Honokiol?
Honokiol, derived from the bark of the Magnolia tree, has been known for centuries for its medicinal properties. It has been traditionally used for its anti-inflammatory, antioxidant, and even anti-cancer effects. In this Herbs And Phytochemicals news report, we explore its new potential as a treatment for aging-related brain disorders like Alzheimer’s disease, as demonstrated in a recent study.
 
The Study at a Glance
A team of researchers from the Department of Neurosciences, Psychology, Drug Research and Child Health (Neurofarba) at the University of Florence and the Department of Dermatology at Emory School of Medicine, Winship Cancer Institute, explored how Honokiol and its synthetic derivative affect microglial cells, which are immune cells in the brain. These cells are critical to maintaining a healthy brain but can cause damage when they become overactive due to inflammation and aging.
 
This study focused on how these compounds can reduce inflammation and cellular senescence, the process where cells stop dividing and begin to release harmful inflammatory substances. Cellular senescence is a key driver of age-related diseases and neurodegeneration.
 
Neuroinflammation and Aging: The Link to Brain Diseases
The aging brain is marked by chronic inflammation, partly due to the overactivity of microglia. This inflammation is often tied to diseases such as Alzheimer’s and Parkinson’s. The accumulation of senescent cells in the brain further drives this process. Once these microglia cells become senescent, they release toxic substances that harm nearby neurons, speeding up the development of neurodegenerative diseases.
 
The research team found that Honokiol and its synthetic derivative, Honokiol Hexafluoro, could slow down or even reverse this harmful process. Their findings suggest these compounds may hold the key to new treatments for a range of brain disorders associated with aging.
 
Key Findings of the Study
The study was carried out using an in vitro model, where microglial cells were exposed to bacterial lipopolysaccharide (LPS), a substance that induces inflammation. Researchers then treated these cells with varying doses of Honokiol and Honokiol Hexafluoro and observed their effects on inflammation and cell aging.
 
-Reduction in Neuroinflammation: When microglia were exposed to LPS , they became inflamed, as seen through changes in their shape and the release of harmful inflammatory substances. However, treatment with Honokiol and Honokiol Hexafluoro significantly reduced these inflammatory responses. The compounds increased the levels of IL-10, an anti-inflammatory cytokine, helping the cells return to a healthier state.
 
-Prevention of Cellular Senescence: LPS exposure also pushed the microglial cells into senescence, a state where they no longer function normally and instead contribute to disease. Both Honokiol and its synthetic derivative prevented this shift, keeping the microglia in a functional state. The study highlighted that these compounds helped reduce markers of aging, such as the protein ß-galactosidase, which is typically elevated in senescent cells.
 
-Impact on the Notch Pathway: The Notch signaling pathway, which is involved in cell communication, was another key focus of this research. Senescent microglia showed an increased expression of the protein Jagged1, part of the Notch signaling system. Both Honokiol and its synthetic version were able to reduce Jagged1 levels, similar to a known Notch inhibitor called DAPT. This suggests that the anti-aging effects of these compounds may be partly due to their impact on Notch signaling.
 
Detailed Breakdown of the Study Findings
-Effect on Microglial Cells’ Shape: The study found that after LPS treatment, microglia shifted from their normal shape to a more elongated and stretched form, which indicates an inflammatory state. Both Honokiol and its synthetic version helped restore the cells to their normal, rounded shape, indicating reduced inflammation.
 
-Cytokine Production: When cells are inflamed, they produce molecules called cytokines, which can either promote or reduce inflammation. LPS-treated cells produced high levels of pro-inflammatory cytokines such as IL-6 and IL-1β. However, Honokiol treatments reduced the production of these harmful cytokines, while increasing levels of IL-10, a key anti-inflammatory molecule.
 
-Markers of Cellular Aging: A hallmark of aging cells is the production of ß-galactosidase. In this study, senescent microglia showed elevated levels of this marker, but both Honokiol and Honokiol Hexafluoro reduced its expression. This suggests that these compounds have strong anti-aging effects, potentially helping to slow down or even reverse cellular aging in the brain.
 
-Reduction in Oxidative Stress: The study also found that Honokiol reduced the production of harmful molecules known as reactive oxygen species (ROS), which are known to cause cellular damage. By lowering ROS levels, the compounds provided additional protection against brain cell aging and damage.
 
Implications for Brain Health
These findings are exciting because they point to a potential new way of treating age-related brain diseases. By reducing inflammation and preventing cellular aging, Honokiol and its synthetic version could help slow down the progression of diseases like Alzheimer’s, Parkinson’s, and other neurodegenerative disorders.

While this study was conducted in vitro (outside the body), the results provide a strong foundation for future research, including clinical trials in humans. If successful, these treatments could offer a new, natural way to protect the brain from the harmful effects of aging and inflammation.
 
Conclusion
The use of natural compounds like Honokiol to combat neuroinflammation and cellular aging holds great promise. This study highlights the potential of Honokiol and Honokiol Hexafluoro in reducing brain inflammation and cellular senescence, processes that are key drivers of neurodegenerative diseases. These findings open the door to further research and the possibility of new therapies for aging-related brain disorders.
 
The study findings were published in the peer-reviewed journal: Cells.
https://www.mdpi.com/2073-4409/13/19/1652
 
For the latest on Herbs and Phytochemicals, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/honokiol-as-a-natural-alpha-glucosidase-inhibitor-for-diabetes-management
 
https://www.thailandmedical.news/news/herbs-and-phytochemicals-international-study-explores-the-phytochemical-honokiol-from-the-plant-magnolia-officinalis-for-its-anticancer-properties